Keywords: |
cancer survival; excision; cancer recurrence; cancer risk; note; united states; cancer radiotherapy; neoplasm recurrence, local; mastectomy; epidermal growth factor receptor 2; editorial; drug effect; breast neoplasms; cancer mortality; mammography; tumor recurrence; breast tumor; carcinoma in situ; partial mastectomy; tamoxifen; receptors, estrogen; invasive carcinoma; hormonal therapy; estrogen receptor; risk reduction; intraductal carcinoma; carcinoma, intraductal, noninfiltrating; raloxifene
|